Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 3/20 | 0.62 |
| ▸ | CCR5 | P51681 | 3/20 | 0.62 |
| ▸ | CCR8 | P51685 | 3/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.52 |
| ▸ | TP53 | P04637 | 6/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 6/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.52 |
| ▸ | LMNA | P02545 | 3/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.52 |
| ▸ | HTT | P42858 | 2/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.52 |
| ▸ | ALPL | P05186 | 1/20 | 0.52 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.52 |
| ▸ | ALPI | P09923 | 1/20 | 0.52 |
| ▸ | ALPG | P10696 | 1/20 | 0.52 |
| ▸ | METAP1 | P53582 | 2/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | BLM | P54132 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12925805 | 0.91 | CCR1 (0.62) | CCR1CCR5CCR8KDM4ETP53 | |
| SCHEMBL12925582 | 0.84 | CCR1 (0.58) | CCR1CCR5CCR8KDM4ETP53 | |
| SCHEMBL9958454 | 0.83 | CCR1 (0.53) | CCR1CCR5CCR8KDM4ETP53 | |
| SCHEMBL18327557 | 0.81 | CCR1 (0.51) | CCR1CCR5CCR8KDM4ETP53 | |
| SCHEMBL30168346 | 0.81 | KDM4E (0.78) | CCR1CCR5CCR8KDM4ETP53 | |
| SCHEMBL30168347 | 0.81 | KDM4E (0.78) | CCR1CCR5CCR8KDM4ETP53 | |
| SCHEMBL17761190 | 0.81 | KDM4E (0.78) | CCR1CCR5CCR8KDM4ETP53 | |
| SCHEMBL4951059 | 0.81 | KDM4E (0.70) | CCR1CCR5CCR8KDM4ETP53 | |
| SCHEMBL30554068 | 0.81 | KDM4E (0.64) | CCR1CCR5CCR8KDM4ETP53 | |
| SCHEMBL17915427 | 0.81 | KDM4E (0.64) | CCR1CCR5CCR8KDM4ETP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210070717-A1 | ORGANIC COMPOUND BASED ON TRIAZINE AND BENZOXAZOLE AND APPLICATION THEREOF IN ORGANIC ELECTROLUMINESCENT DEVICE | JIANGSU SUNERA TECHNOLOGY CO., LTD. (CN) | 2021-03-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210070717-A1 | ORGANIC COMPOUND BASED ON TRIAZINE AND BENZOXAZOLE AND APPLICATION THEREOF IN ORGANIC ELECTROLUMINESCENT DEVICE | OCIAD1, EED, OCIAD2 | CCR1 4277/4885CCR5 3798/4885CCR8 2639/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.